Bernard Poussot has been appointed president and chief executive officer, Wyeth, effective January 1, 2008. He replaces Robert Essner, who will continue as chairman of the board of directors for the transition period.

Mr. Poussot joined the company in 1986 and was appointed president of Wyeth-Ayerst International in 1996. He was promoted to president of the worldwide pharmaceutical business in 1997 and in 2002 he was promoted to executive vice president, Wyeth, responsible for Wyeth R&D. In April 2006, Mr. Poussot was promoted to president and vice chairman, Wyeth, and in January 2007 to the position of president, chief operating officer and vice chairman, Wyeth.

“The election of Mr. Poussot is a result of the company’s ongoing succession management process that has been an important focus of the Wyeth board of directors and management. Bernard is exceptionally well-qualified for this role, and we have built a world-class management team to support him and the Company,” said Robert Essner.

News from our sister sites